Latest debt-to-equity ratio
Nautilus Biotechnology Debt-to-equity ratio
Direct answer
Nautilus Biotechnology's debt-to-equity ratio is 21.22%.
The verified market snapshot reports 21.22%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 21, 2026.
Get free Nautilus Biotechnology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 21.22%
Explore related company data
View Nautilus Biotechnology's market capitalizationView Nautilus Biotechnology's price-to-book ratioView Nautilus Biotechnology's return on equityView Nautilus Biotechnology's dividend yieldView Nautilus Biotechnology's 52-week price rangeView Nautilus Biotechnology's profit marginView all Nautilus Biotechnology key metricsReturn to Nautilus Biotechnology profile